Latest Breaking News On - Stijn van rompay - Page 8 : comparemela.com

Hyloris Pharmaceuticals Reports 2023 Half-Year Results and provides Business Outlook

Hyloris Pharmaceuticals Reports 2023 Half-Year Results and provides Business Outlook
finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.

Waals gewestSan franciscoUnited statesFrance generalCity ofUnited kingdomWalloon regionComunidad autonoma de catalunaStijn van rompayJean luc vandebroekDegroof petercamSven watthyOlivier declercqUs food drug administrationHyloris pharmaceuticals sa euronext brusselsInvestor relations communications

Hyloris Pharmaceuticals Reports 2023 Half-Year Results and provides Business Outlook

Hyloris Pharmaceuticals Reports 2023 Half-Year Results and provides Business Outlook
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Waals gewestComunidad autonoma de catalunaUnited statesFrance generalWalloon regionSan franciscoCity ofUnited kingdomOlivier declercqDegroof petercamStijn van rompayJean luc vandebroekSven watthyUs food drug administration suchHyloris pharmaceuticals sa euronext brusselsInvestor relations communications

Hyloris announces enrolment of first patient in a 4-arm clinical trial of Alenura(TM)

Hyloris announces enrolment of first patient in a 4-arm clinical trial of Alenura(TM)
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Stijn van rompayVaneltix pharma incVan rompayChief executive officerVaneltix pharma

Hyloris shareholders approve all resolutions at the Annual

56,22% of shares represented physically, virtually or by proxy voteAll documents related to the 2023 AGM are available on the Hyloris website Regulated.

Jean luc vandebroekStijn van rompaySven watthyHyloris pharmaceuticalsInvestor relations communicationsHyloris pharmaceuticals sa euronext brusselsInside informationEuronext brusselsAnnual general meetingVan rompayLuc vandebroekInvestor relations

Hyloris shareholders approve all resolutions at the Annual General Meeting

56,22% of shares represented physically, virtually or by proxy voteAll documents related to the 2023 AGM are available on the Hyloris website Regulated Information – Inside Information -. | June 13, 2023

Sven watthyJean luc vandebroekStijn van rompayHyloris pharmaceuticalsHyloris pharmaceuticals sa euronext brusselsInvestor relations communicationsInside informationEuronext brusselsAnnual general meetingVan rompayLuc vandebroekInvestor relations